INFLUENCE OF TUMOR HYPOXIA ON STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR): RESPONSE TO DRS. MEYER AND TIMMERMAN

被引：1
|
作者：
Brown, Martin [1 ]
Lao, Billy [1 ]
Diehn, Maximillian [1 ]
Carlson, David [2 ]
机构：
[1] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[2] Yale Univ, Sch Med, New Haven, CT USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2011年 / 79卷 / 05期
关键词：
D O I：
10.1016/j.ijrobp.2010.11.013
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1600 / 1600
页数：1
相关论文
共 50 条
  • [31] Total tumor volume as a predictor of survival in patients with multiple oligometastases treated with stereotactic ablative radiotherapy (SABR)
    Franzese, Ciro
    Vernier, Veronica
    Franceschini, Davide
    Comito, Tiziana
    Navarria, Pierina
    Clerici, Elena
    Teriaca, Maria Ausilia
    Massaro, Maria
    Di Cristina, Luciana
    Marini, Beatrice
    Galdieri, Carmela
    Mancosu, Pietro
    Tomatis, Stefano
    Scorsetti, Marta
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (12) : 10495 - 10503
  • [32] Stereotactic body radiotherapy (SBRT)/stereotactic ablative body radiotherapy (SABR) for "radioresistant" renal cell carcinoma (RCC)
    Ishiyama, Hiromichi
    Blanco, Angel I.
    Lo, Simon S.
    Butler, E. Brian
    Teh, Bin S.
    JOURNAL OF RADIATION ONCOLOGY, 2014, 3 (04) : 339 - 346
  • [33] Evaluation of Volumetric Response Assessment from Stereotactic Ablative Radiotherapy (SABR) for Renal Cell Carcinoma (RCC)
    Schep, D.
    Dayes, I.
    Lukka, H.
    Quan, K.
    Kapoor, A.
    Vansantvoort, J.
    Chow, T.
    Swaminath, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E434 - E434
  • [34] EVALUATION OF VOLUMETRIC RESPONSE ASSESSMENT FROM STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR) FOR RENAL CELL CARCINOMA (RCC)
    Schep, Daniel
    Dayes, Ian
    Lukka, Himanshu
    Quan, Kimmen
    Kapoor, Anil
    Vansantvoort, Jasmin
    Chow, Tom
    Swaminath, Anand
    RADIOTHERAPY AND ONCOLOGY, 2023, 186 : S67 - S67
  • [35] Stereotactic ablative body radiotherapy (SABR) for multiple lung tumours: hazardous or harmless?
    Allos, B.
    Carruthers, H.
    Harrop, V.
    Stange, D.
    Misheva, T.
    Stevenson, R.
    Watkins, S.
    Ghafoor, Q.
    LUNG CANCER, 2018, 115 : S58 - S58
  • [36] Adrenal Insufficiency following Stereotactic Ablative Radiotherapy (SAbR) of Adrenal Gland Metastases
    Hamidi, Oksana
    Miljanic, Mihailo
    Tumyan, Gayane
    Christie, Alana
    Mirfakhraee, Sasan
    Ali, Sadia
    Dohopolski, Michael
    Gottumukkala, Sujana
    Brugarolas, James
    Timmerman, Robert
    Hannan, Raquibul
    CANCERS, 2024, 16 (18)
  • [37] Efficacy and safety profile of Stereotactic Ablative Radiotherapy (SABR) for multiple lung primaries
    Littlejohns, A.
    Janjua, T.
    Murray, P.
    Jain, P.
    Clarke, K.
    Dickinson, P.
    Teo, M.
    Saha, A.
    Franks, K.
    Sun, F.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S542 - S542
  • [38] Stereotactic Ablative Radiotherapy (SABR) for Non-Small Cell Lung Cancer
    Iyengar, Puneeth
    Westover, Kenneth
    Timmerman, Robert D.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 34 (06) : 845 - 854
  • [39] Clinical implementation of stereotactic ablative radiotherapy (SABR) for lung early stage NSCLC
    Routsis, D.
    Dean, J.
    Archer, S.
    Ferriera, C.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S304 - S304
  • [40] Quantification of interplay and gradient effects for lung stereotactic ablative radiotherapy (SABR) treatments
    Tyler, Madelaine K.
    JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2016, 17 (01): : 158 - 166
12345